niclosamide (AR-001)
/ Aeon Respire
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 20, 2024
Inhibition of the Ion Channel TMEM16A With Niclosamide Inhalation Powder Reduces Inflammation, Bronchoconstriction, and Airway Hyperresponsiveness in a Large Animal Model of Asthma
(ATS 2024)
- "SCP-niclosamide inhalation powder as a trifunctional bronchodilator, mucoregulator and anti-inflammatory could be an important additional treatment option for patients who suffer from severe, uncontrolled disease."
Preclinical • Asthma • Immunology • Infectious Disease • Inflammation • Pneumonia • Pulmonary Disease • Respiratory Diseases • ANO1 • TSLP
1 to 1
Of
1
Go to page
1